Conference abstract · 7 Aug 2023
Conference abstractPublished 17 Nov 2021
New horizon for the middle ear surgery with regeneration of the tympanic membrane
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent progress in regenerative medicine has provided us with various scaffolds and growth factors that make it possible to accelerate tissue repair. Applying modern in situ tissue engineering principles, we developed a new regenerative treatment for tympanic membrane (TM) perforation using a combination of basic fibroblast growth factor (b-FGF), gelatin sponge, and fibrin glue without the need for conventional surgical procedures and cell transplantation. There are numerous advantages to this regenerative treatment. Skin incisions and harvesting of autologous tissues are not required. It is possible to regenerate normal TM morphology fully. High success/cure rates and ideal hearing improvements are possible. It can be performed within 20 minutes and is a simple, easy outpatient procedure. This regenerative treatment for the TM perforation was approved in November 2019 by the National Health Insurance in Japan. Before the approval, Retympa® (Norvel Pharma Inc., Tokyo, Japan), a specialized medicine for TM perforation, received pharmaceutical approval in Japan. We have been limited the adaptation of this treatment to patients with dry and no active inflammation in the TM and the tympanic cavity. In addition, temporal bone CTs were analyzed to ensure that all patients had proper aeration in the mastoid and tympanic cavities before treatment. We also initially selected patients without cholesteatomas or tumors in the tympanic cavity and no severe calcification/osseous metaplasia of the TM. However, to expand its adaptation, we attempted to apply this treatment to patients with the above lesions localized to the tympanic cavity by an endoscope. This new regenerative therapy is useful not only for patients with simple TM perforations but also for some patients who need tympanoplasty. This innovative regenerative therapy that is an easy, safe, cost-effective, and minimally-invasive treatment will open the new horizon of middle ear surgery.
Keywords
Subjects
SurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Surgery: Case Report.
Conference abstract · 7 Aug 2023
Total knee arthroplasty in patient above 95 years old: A case report
Conference abstract · 7 Aug 2023
The effectiveness of virtual reality (VR) in arthroplasty training for surgical trainees: a systematic review with meta-analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSurgery: Case Report
- SubjectSurgery
- BylineArticles whose byline prints “Shin-ichi Kanemaru”
- BylineArticles whose byline prints “Rie Kanai”
